Ignite Creation Date:
2025-12-24 @ 11:35 PM
Ignite Modification Date:
2026-05-18 @ 6:38 PM
Study NCT ID:
NCT05425056
Status:
COMPLETED
Last Update Posted:
2025-09-24
First Post:
2022-06-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study Testing the Use of a Perivascular Sirolimus Formulation (Sirogen) in ESRD Patients Undergoing AV Fistula Surgery
Sponsor:
Vascular Therapies, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Complication of Renal Dialysis | View |
| None | End Stage Renal Disease | View |
| None | End Stage Kidney Disease | View |
| None | ESRD | View |
| None | Chronic Kidney Failure | View |
| None | Complication of Hemodialysis | View |
| None | Vascular Access Complication | View |
| None | Arteriovenous Fistula | View |